Biotech Startups

4 investors

Climax (Bettani) develops dairy-free cheeses that match the taste, texture, melt and stretch of dairy cheese while providing 80–100% of the protein. Its products use a patented plant protein called Caseed, derived from seeds of regenerative crops, to make mozzarella, jack, cheddar, and feta-style cheeses for people avoiding dairy, soy, and nut allergens.

4 investors

Coagulo develops a portable point-of-care testing platform for coagulation disorder diagnosis and management using microfluidic technology and data analytics. The platform enables healthcare providers to perform comprehensive coagulation testing with drops of blood and deliver results within 10 minutes.

4 investors

Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision. The company focuses on treating retinal vascular diseases and other genetic conditions where traditional gene therapy delivery has been limited.

4 investors

Collegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions. It serves patients living with serious medical conditions and the healthcare professionals caring for them.

4 investors

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women. It focuses on evidence-based therapies for life-threatening complications of pregnancy.

4 investors

Combinati developed the QuantStudio Absolute Q Digital PCR System, which uses microfluidic array plate (MAP) technology for detection and quantification of nucleic acids, rare mutations, and genome editing events. The platform serves research laboratories for applications such as next-generation sequencing library quantification and CRISPR-Cas9 editing analysis.

4 investors

Concarlo Therapeutics is a biotech company developing cancer therapies aimed at the p27 target to treat drug-resistant cancers. It focuses on precision oncology, advancing a lead compound through preclinical development.

4 investors

Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories. The platform enables rapid identification and prioritization of clinically relevant genetic variants from sequencing data, with applications in cancer mutation detection, germline variant analysis, and pathogen identification.

4 investors

Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico. It uses these computational methods to identify and design therapeutics.

4 investors

Developing therapeutics targeting epigenetic regulators to modulate gene expression; acquired by MorphoSys in June 2021 for $1.7B.

4 investors

Core Biogenesis is a French biotech that uses an oleosome fusion platform to grow active peptides and proteins (such as EGF and FGF-2) inside camelina seeds, producing formulation-ready topical delivery carriers for skin and scalp. It supplies these recombinant protein actives to the cosmetics and personal care industry, serving formulators, R&D teams, and brands.

4 investors

Cori Clinical builds an AI platform that automates the authoring and management of clinical trial documentation, including protocols, consent forms, and regulatory submissions. The platform serves clinical development teams by reducing manual document preparation and ensuring consistency across all trial-related paperwork.

4 investors

Corvus Pharmaceuticals is a biopharmaceutical company developing immunology-focused medicines that target cellular components of the immune system, with therapeutic focus on immune diseases and cancer.

4 investors

Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.

4 investors

Counsyl was a clinical genetic-screening company offering DNA carrier screening for family planning, prenatal screening, and inherited cancer risk tests, processed in its own CLIA-certified lab. Co-founded in 2007 with Balaji Srinivasan as CTO, it screened hundreds of thousands of patients before Myriad Genetics acquired it for $375 million in 2018.

4 investors

Cradle uses AI to help scientists design and engineer proteins, decoding and rewriting biology to develop new food sources, materials, and therapeutics. It serves research scientists and offers models validated in its own lab before delivery to customers.

4 investors

Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.

4 investors

Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates. It serves biopharmaceutical companies developing oncology therapeutics and is also building its own suite of antibody therapeutics with enhanced tumour penetration.

4 investors

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease. It pairs this delivery technology with an AI/ML nucleic acid engineering platform (NucleIQ) to design nucleic acid therapies.

4 investors

Crinetics is a pharmaceutical company focused on discovering, developing, and commercializing therapies for endocrine diseases and endocrine-related conditions.

4 investors

Cryogenx develops CGX1, a portable body cooling device designed to treat heatstroke and prevent heat-related deaths. The company targets defense, first responder, sports, and industrial sectors with medical technology intended to rapidly reduce core body temperature.

4 investors

Develops software tools for researchers to conduct scientific analysis and answer biological research questions. The company focuses on making research tools accessible and scalable for scientists.

4 investors

CubaseBio develops spatial biology tools that enable three-dimensional analysis of biological samples at scale, for drug discovery and biological research.

4 investors